Skip to main content

Contents

Go back
Overview
Stability Information
Alternative Suppliers
Related Formulations

Actual Medicinal Product (AMP) Almuriva 13.3mg/24hours transdermal patches (Sandoz Ltd)

Stability Information

Stability
We do not have stability information for these medicines and therefore cannot make a recommendation on suitability in an MCA.
Notes
There are no stability notes available for this medicine.
Generic
Rivastigmine
Formulation
Rivastigmine 13.3mg/24hours transdermal patches
  • Rivastigmine
    • Rivastigmine 13.3mg/24hours transdermal patches
      • Almuriva 13.3mg/24hours transdermal patches (Sandoz Ltd)

Alternative Suppliers (8)

Exelon 13.3mg/24hours transdermal patches (Novartis Pharmaceuticals UK Ltd)
Erastig 13.3mg/24hours transdermal patches (Teva UK Ltd)
Exelon 13.3mg/24hours transdermal patches (CST Pharma Ltd)
Alzest 13.3mg/24hours transdermal patches (Dr Reddy's Laboratories (UK) Ltd)
Almuriva 13.3mg/24hours transdermal patches (Sandoz Ltd)
Rivastigmine 13.3mg/24hours transdermal patches (A A H Pharmaceuticals Ltd)
Voleze 13.3mg/24hours transdermal patches (Advanz Pharma)
Rivastigmine 13.3mg/24hours transdermal patches (Luye Pharma Ltd)


Related Formulations (7)

Rivastigmine 4.6mg/24hours transdermal patches
Rivastigmine 9.5mg/24hours transdermal patches
Rivastigmine 1.5mg capsules
Rivastigmine 3mg capsules
Rivastigmine 4.5mg capsules
Rivastigmine 6mg capsules
Rivastigmine 13.3mg/24hours transdermal patches